Colon Cancer Clinical Trial

Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections

Summary

This is a study to determine how the viscosity (thickness) of an FDA approved gel affects the ease in which endoscopic mucosal resections (EMR) can be performed.

View Full Description

Full Description

This is a study to determine how the viscosity (thickness) of an FDA approved gel made by Cook medical affects the ease in which endoscopic mucosal resections (EMR) - a type of endoscopic surgery performed for localised cancer - can be performed when the gel is injected submucosally. The lifting characteristics of the gel will be assessed by height and diameter and ease with which the subsequent EMR dissection can be performed. These characteristics would be assessed on excised human stomachs and colon, which are harvested during routine sleeve gastrectomy surgeries or colectomies, in an ex-vivo manner.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Pts undergoing sleeve gastrectomy
Pts undergoing colectomy

Exclusion Criteria:

Unable to give or understand consent
All of the excised tissue will be needed for diagnostic purposes

Study is for people with:

Colon Cancer

Phase:

Phase 3

Study ID:

NCT02519140

Recruitment Status:

Withdrawn

Sponsor:

Antonios Likourezos

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Maimonides Medical Center
Brooklyn New York, 11219, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Phase:

Phase 3

Study ID:

NCT02519140

Recruitment Status:

Withdrawn

Sponsor:


Antonios Likourezos

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.